Manning & Napier Group's TMO Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 6,384 shares of Thermo Fisher Scientific Inc. (TMO) worth $3.72 M, representing 0.05% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in TMO, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2020, adding 142,550 shares. Largest reduction occurred in Q4 2025, reducing 284,512 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -284,512 | Reduce 97.81% | 6,384 | $583.45 |
| Q3 2025 | -21,457 | Reduce 6.87% | 290,896 | $485.02 |
| Q2 2025 | -50,758 | Reduce 13.98% | 312,353 | $405.48 |
| Q1 2025 | +95,509 | Add 35.69% | 363,111 | $497.60 |
| Q4 2024 | +73,575 | Add 37.92% | 267,602 | $520.23 |
| Q3 2024 | +52,498 | Add 37.09% | 194,027 | $618.57 |
| Q2 2024 | -2,276 | Reduce 1.58% | 141,529 | $553.00 |
| Q1 2024 | -1,642 | Reduce 1.13% | 143,805 | $581.20 |
| Q4 2023 | +2,453 | Add 1.72% | 145,447 | $530.79 |
| Q3 2023 | +2,655 | Add 1.89% | 142,994 | $506.17 |
| Q2 2023 | +1,184 | Add 0.85% | 140,339 | $521.75 |
| Q1 2023 | +1,219 | Add 0.88% | 139,155 | $576.37 |
| Q4 2022 | -1,612 | Reduce 1.16% | 137,936 | $550.69 |
| Q3 2022 | -2,002 | Reduce 1.41% | 139,548 | $507.18 |
| Q2 2022 | -3,742 | Reduce 2.58% | 141,550 | $543.27 |
| Q1 2022 | -25,613 | Reduce 14.99% | 145,292 | $590.64 |
| Q4 2021 | -7,628 | Reduce 4.27% | 170,905 | $667.23 |
| Q3 2021 | -5,842 | Reduce 3.17% | 178,533 | $571.32 |
| Q2 2021 | +664 | Add 0.36% | 184,375 | $504.46 |
| Q1 2021 | +3,085 | Add 1.71% | 183,711 | $456.37 |
| Q4 2020 | -18,421 | Reduce 9.25% | 180,626 | $465.77 |
| Q3 2020 | -13,018 | Reduce 6.14% | 199,047 | $441.51 |
| Q2 2020 | -6,610 | Reduce 3.02% | 212,065 | $362.33 |
| Q1 2020 | +142,550 | Add 187.26% | 218,675 | $283.59 |
| Q4 2019 | -4,760 | Reduce 5.88% | 76,125 | $324.86 |
| Q3 2019 | +410 | Add 0.51% | 80,885 | $291.24 |
| Q2 2019 | -1,275 | Reduce 1.56% | 80,475 | $293.66 |
| Q1 2019 | -31,700 | Reduce 27.94% | 81,750 | $273.70 |
| Q4 2018 | -13,680 | Reduce 10.76% | 113,450 | $223.78 |
| Q3 2018 | -80 | Reduce 0.06% | 127,130 | $244.07 |
| Q2 2018 | -4,720 | Reduce 3.58% | 127,210 | $207.12 |
| Q1 2018 | -33,540 | Reduce 20.27% | 131,930 | $206.44 |
| Q4 2017 | +165,471 | Add 0.00% | 165,470 | $189.88 |
| Q3 2017 | -100,615 | Reduce 37.03% | 171,095 | $189.19 |
| Q2 2017 | -55,793 | Reduce 17.04% | 271,710 | $174.47 |
| Q1 2017 | -87,708 | Reduce 21.12% | 327,503 | $153.60 |
| Q4 2016 | +1,670 | Add 0.40% | 415,211 | $141.09 |
| Q3 2016 | -217,799 | Reduce 34.50% | 413,541 | $159.06 |
| Q2 2016 | -56,550 | Reduce 8.22% | 631,340 | $147.76 |
| Q1 2016 | +102,380 | Add 17.49% | 687,890 | $141.59 |
| Q4 2015 | +81,130 | Add 16.09% | 585,510 | $141.85 |
| Q3 2015 | +504,380 | New Buy | 504,380 | $122.28 |
Manning & Napier Group's Thermo Fisher Scientific Investment FAQs
Manning & Napier Group first purchased Thermo Fisher Scientific Inc. (TMO) in Q3 2015, acquiring 504,380 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Thermo Fisher Scientific Inc. (TMO) for 42 quarters since Q3 2015.
Manning & Napier Group's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q3 2015, adding 504,380 shares worth $61.67 M.
According to the latest 13F filing for Q4 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 6,384 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $3.72 M.
As of the Q4 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 0.05% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Thermo Fisher Scientific Inc. (TMO) was 687,890 shares, as reported at the end of Q1 2016.